KIMBERLY THOMAS: Open Payments
NPI 1861723066 · CLARKSVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$287 in 9 payments from 6 companies in 2025. Trend: 2023 $125 · 2024 $73 · 2025 $287
Food & beverage: $287
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 1 | $125 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: DUPIXENT, KEYTRUDA, XIFAXAN, CAPLYTA, REXULTI, INGREZZA.
Industry payments across TN — which companies pay providers there.
